What is the first-line treatment for coccidioidomycosis after exposure in Southwestern USA?

• A. Amphotericin B
• B. Fluconazole
• C. Itraconazole
• D. Ketoconazole

Answer: (B)

The first-line treatment for coccidioidomycosis, particularly following exposure in endemic areas like the Southwestern USA, is fluconazole. This fungal infection is caused by the Coccidioides species, which can lead to a range of clinical manifestations, including mild pulmonary infections that may resolve without treatment, as well as more severe forms that require antifungal therapy.

Fluconazole is particularly effective due to its favorable pharmacokinetic profile, oral bioavailability, and the fact that it can penetrate well into tissues. It is typically used for the management of moderate to severe pulmonary coccidioidomycosis and disseminated disease. This drug is preferred for chronic pulmonary infections and for the management of meningitis due to its central nervous system penetration.

Other antifungal agents listed might be used in certain situations or specific cases but are generally not the first-line treatments. Amphotericin B is typically reserved for severe cases or for those who cannot tolerate fluconazole. Itraconazole may be used in cases of chronic disease but is not the most preferred for initial treatment. Ketoconazole is less commonly used due to its side effect profile and the availability of safer alternatives.